Evidence map›Paper›PMID 31393047›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.

Hanspeter Rottensteiner, Birgit K Seyfried, Stefan Kaufmann, Christian Fiedler, Jing-Fei Dong, X Long Zheng, Barbara Plaimauer, Friedrich Scheiflinger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hanspeter RottensteinerBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Birgit K SeyfriedBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Stefan KaufmannBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Christian FiedlerBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Jing-Fei DongBloodWorks Northwest Research Institute, University of Washington, Seattle, WA, USA.
X Long ZhengDivision of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-1680-5295
Barbara PlaimauerBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Friedrich ScheiflingerBaxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Takeda (Austria) · ATUniversity of Alabama at Birmingham · USUniversity of Washington · US

Funding

Pathogenesis of Thrombotic MicroangiopathyR01HL126724 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHENG, X. LONG · 2015 to 2018
$1.8M
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic PurpuraR01HL144552 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ZHENG, X. LONG · 2019 to 2022
$1.8M
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic PurpuraR01HL115187 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHENG, X. LONG · 2013 to 2016
$1.6M
NHLBI NIH HHS R01 HL115187NHLBI NIH HHS R01 HL126724NHLBI NIH HHS R01 HL144552
6 · The paper itself

Abstract

backgroundADAMTS13, a plasma metalloprotease, cleaves von Willebrand factor (VWF) to regulate its function. Additionally, ADAMTS13 is thought to regulate lateral association of VWF multimers to form fibrillar structures through its free thiols.

objectiveThe purpose of the present study is to obtain direct evidence for ADAMTS13 to engage in thiol/disulfide exchange reactions.

methodsCovalent complexes between ADAMTS13 and VWF were determined by agarose gel electrophoresis under nonreducing conditions. Free thiols in ADAMST13 were identified by a reversed phase high-performance liquid chromatography electrospray ionization quadrupole time-of-flight mass spectrometry system.

resultsWe demonstrate formation of covalent linkage between ADAMTS13 and VWF, which is time, concentration, temperature, and shear dependent. This interaction is independent of proteolytic activity of ADAMTS13 but depends on the C-terminal domains comprising the fifth through eighth thrombospondin type 1 repeats and C1r/C1s, Uegf, Bmp1 (CUB) domains. The interaction can be blocked by thiol-reactive agents, indicating that association is accomplished through disulfide bridge formation. Several partially reduced free thiols are identified in ADAMTS13, with cysteines 1254 and 1275 being the most prominent, although a point mutation (C1275S) in ADAMTS13 does not alter its ability to form covalent linkages with VWF. This suggests functionally relevant disulfide plasticity in ADAMTS13. Interestingly, ADAMTS13 also forms homo-oligomers under the same conditions as required for the generation of hetero-oligomeric complexes of ADAMTS13 and VWF.

conclusionsOur results suggest that a dynamic network of free thiols in ADAMTS13 undergoing intra- and inter-molecular redox reactions may add another layer of regulation to VWF function under various conditions.

Indexed as

ADAMTS13 ProteinAnimalsCHO CellsCricetulusCysteineHumansOxidation-ReductionProtein BindingProtein MultimerizationProtein Structure, QuaternaryProteolysisSubstrate SpecificitySulfhydryl CompoundsTemperatureTime Factorsvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanCysteineSulfhydryl Compoundsvon Willebrand FactorADAMTS13catalysis-independent regulationfree thiolshomo-oligomerizationvon Willebrand factor

Identifiers

PMID31393047
PMCPMC6916347
OpenAlexW2967294805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.